Fig. 6From: Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine modela–c P1 T2-FLAIR imaging at 2 weeks prior to treatment (a), 1 month (b), and 6 months (c) following 90Y-RE. d–f T1 post-contrast imaging at 2 weeks prior to treatment (d), 1 month (e), and 6 months (f) following 90Y-RE. At 1 month post-therapy, there is a decrease in lesion size with a resolution of perilesional edema and absence of contrast enhancement. The resolution of midline shift without evidence of cortical atrophy was also noted. Treatment effect is maintained at 6 months with a continued decrease in lesion size. Additional images showing the progression of P4 which had a less impressive response are shown in the supplementBack to article page